BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26296158)

  • 1. Glyceollin Effects on MRP2 and BCRP in Caco-2 Cells, and Implications for Metabolic and Transport Interactions.
    Chimezie C; Ewing A; Schexnayder C; Bratton M; Glotser E; Skripnikova E; Sá P; Boué S; Stratford RE
    J Pharm Sci; 2016 Feb; 105(2):972-981. PubMed ID: 26296158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein and Glyceollin Effects on ABCC2 (MRP2) and ABCG2 (BCRP) in Caco-2 Cells.
    Schexnayder C; Stratford RE
    Int J Environ Res Public Health; 2015 Dec; 13(1):ijerph13010017. PubMed ID: 26703673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
    Dahan A; Amidon GL
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of efflux transport of the PDE5 inhibitors, vardenafil and sildenafil.
    Choi MK; Song IS
    J Pharm Pharmacol; 2012 Aug; 64(8):1074-83. PubMed ID: 22775210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular Pharmacokinetic Model-Based Analysis of Genistein, Glyceollin, and MK-571 Effects on 5 (and 6)-Carboxy-2',7'-Dichloroflourescein Disposition in Caco-2 Cells.
    Drennen C; Gorse E; Stratford RE
    J Pharm Sci; 2018 Apr; 107(4):1194-1203. PubMed ID: 29247742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells.
    Ye L; Yang X; Yang Z; Gao S; Yin T; Liu W; Wang F; Hu M; Liu Z
    Toxicol Lett; 2013 Feb; 216(2-3):86-99. PubMed ID: 23200901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
    Xiao L; Yi T; Chen M; Lam CW; Zhou H
    Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells.
    Sampson KE; Brinker A; Pratt J; Venkatraman N; Xiao Y; Blasberg J; Steiner T; Bourner M; Thompson DC
    Drug Metab Dispos; 2015 Feb; 43(2):199-207. PubMed ID: 25388687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the antiretroviral drug 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions.
    Liu Y; Wang Y; Peng Y; Liu B; Ma F; Jiang J; Wang Q; Chang J
    Pharmazie; 2018 Sep; 73(9):503-507. PubMed ID: 30223932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Determine the Disposition of Esculetin-7-O-Glucuronide and 4-Methylesculetin-7-O-Glucuronide.
    Li Y; Song W; Ou X; Luo G; Xie Y; Sun R; Wang Y; Qi X; Hu M; Liu Z; Zhu L
    Drug Metab Dispos; 2019 Mar; 47(3):203-214. PubMed ID: 30602435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides.
    Qin Z; Li S; Yao Z; Hong X; Wu B; Krausz KW; Gonzalez FJ; Gao H; Yao X
    Food Funct; 2018 Mar; 9(3):1410-1423. PubMed ID: 29318243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2.
    Ma L; Qin Y; Shen Z; Bi H; Hu H; Huang M; Zhou H; Yu L; Jiang H; Zeng S
    J Ethnopharmacol; 2015 Aug; 172():430-5. PubMed ID: 26183576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2.
    Mease K; Sane R; Podila L; Taub ME
    J Pharm Sci; 2012 May; 101(5):1888-97. PubMed ID: 22359351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aconitum alkaloids, the major components of Aconitum species, affect expression of multidrug resistance-associated protein 2 and breast cancer resistance protein by activating the Nrf2-mediated signalling pathway.
    Wu JJ; Zhu YF; Guo ZZ; Lou YM; He SG; Guan Y; Zhu LJ; Liu ZQ; Lu LL; Liu L
    Phytomedicine; 2018 May; 44():87-97. PubMed ID: 29277460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application and limitation of inhibitors in drug-transporter interactions studies.
    Wang Q; Strab R; Kardos P; Ferguson C; Li J; Owen A; Hidalgo IJ
    Int J Pharm; 2008 May; 356(1-2):12-8. PubMed ID: 18272304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers.
    Schutte ME; Freidig AP; van de Sandt JJ; Alink GM; Rietjens IM; Groten JP
    Toxicol Appl Pharmacol; 2006 Dec; 217(2):204-15. PubMed ID: 16997339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin.
    Liu W; Feng Q; Li Y; Ye L; Hu M; Liu Z
    Toxicol Appl Pharmacol; 2012 Dec; 265(3):316-24. PubMed ID: 22982073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance.
    Kwatra D; Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
    Int J Pharm; 2010 Aug; 395(1-2):114-21. PubMed ID: 20573570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfonation of raloxifene in HEK293 cells overexpressing SULT1A3: Involvement of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in excretion of sulfate metabolites.
    Zhou X; Wang S; Sun H; Wu B
    Drug Metab Pharmacokinet; 2015 Dec; 30(6):425-33. PubMed ID: 26611713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efflux and uptake transporters involved in the disposition of bazedoxifene.
    Lušin TT; Mrhar A; Stieger B; Kristl A; Berginc K; Trontelj J
    Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):251-7. PubMed ID: 25631963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.